Glucocorticoid-mediated E4BP4 promotes apoptotic effects in CEM lymphocytic leukaemia cells through upregulation, whereas TRAF4 expression in contrast to E4BP4 inhibits apoptosis in lymphocytic leukaemia cells (87) (Table 2). The gene discussed is NFIL3; the disease is lymphoid leukemia.